Expression and regulation of versican in neural precursor cells and their lineages

Acta Pharmacologica Sinica

Volumn 28, Issue 10, 2007, Pages 1519-1530

  Gu, Wen Li ^a,b   Fu, Sai Li ^a   Wang, Yan Xia ^a   Li, Ying ^a   Wang, Xiao Fei ^a   Xu, Xiao Ming ^a,c   Lu, Pei Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c University of Louisville School of Medicine   (United States)

Author keywords

Chondroitin sulfate proteoglycans; Neural precursor cells; Oligodendrocyte precursor cells; Oligodendrocytes; Pro inflammatory cytokines; Versican

Indexed keywords

CYTOKINE; GAMMA INTERFERON; ISOPROTEIN; PROTEOCHONDROITIN SULFATE; TUMOR NECROSIS FACTOR ALPHA; VERSICAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; GENETIC TRANSCRIPTION; IMMUNOCYTOCHEMISTRY; INFLAMMATION; NERVE CELL; NERVE FIBER REGENERATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; NEURONS; OLIGODENDROGLIA; PROTEIN ISOFORMS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA; VERSICANS;

EID: 34848879763     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00659.x     Document Type: Article

References (50)

1. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 1989 109 : 317 30.
2. Mongiat M, Fu J, Oldershaw R, Greenhalgh R, Gown AM, Iozzo RV. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem 2003 278 : 17 491 9.
3. Walker HA, Whitelock JM, Garl PJ, Nemenoff RA, Stenmark KR, Weiser-Evans MC. Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling. Mol Biol Cell 2003 14 : 1941 52.
4. Oohira A, Matsui F, Matsuda M, Shoji R. Developmental change in the glycosaminoglycan composition of the rat brain. J Neurochem 1986 47 : 588 93.
5. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989 8 : 2975 81.
6. Shinomura T, Nishida Y, Ito K, Kimata K. cDNA cloning of PGM, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem 1993 268 : 14 461 9.
7. Paulus W, Baur I, Dours-Zimmermann MT, Zimmermann DR. Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 1996 55 : 528 33.
8. Bignami A, Perides G, Rahemtulla F. Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain. J Neurosci Res 1993 34 : 97 106.
9. Ang LC, Zhang Y, Cao L, Yang BL, Young B, Kiani C, et al. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 1999 58 : 597 605.
10. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002 14 : 617 23.
11. Zhang Y, Cao L, Yang BL, Yang BB. The G3 domain of versican enhances cell proliferation via epidermal growth factor-like motifs. J Biol Chem 1998 273 : 21 342 51.
12. Zhang Y, Cao L, Kiani CG, Yang BL, Yang BB. The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. J Biol Chem 1998 273 : 33 054 63.
13. Zhang Y, Cao L, Kiani C, Yang BL, Hu W, Yang BB. Promotion of chondrocyte proliferation by versican mediated by G1 domain and EGF-like motifs. J Cell Biochem 1999 73 : 445 57.
14. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995 270 : 958 65.
15. Lemire JM, Braun KR, Maurel P, Kaplan ED, Schwartz SM, Wight TN. Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999 19 : 1630 9.
16. Aspberg A, Binkert C, Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc Natl Acad Sci USA 1995 92 : 10 590 4.
17. Isogai Z, Aspberg A, Keene DR, Ono RN, Reinhardt DP, Sakai LY. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem 2002 277 : 4565 72.
18. Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, Miyasaka M. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem 2000 275 : 35 448 56.
19. Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T, Kimata K, et al. Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 2003 278 : 41 205 12.
20. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem 1992 267 : 10 003 10.
21. Olin AI, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A. The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 2001 276 : 1253 61.
22. Bandtlow CE, Zimmermann DR. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 2000 80 : 1267 90.
23. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995 121 : 2303 12.
24. Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem 1998 273 : 15 758 64.
25. Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR. Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 2000 113 : 807 16.
26. Wu Y, Sheng W, Chen L, Dong H, Lee V, Lu F, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 2004 15 : 2093 104.
27. Asher RA, Morgenstern DA, Shearer MC, Adcock KH, Pesheva P, Fawcett JW. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci 2002 22 : 2225 36.
28. Hu JG, Fu SL, Zhang KH, Li Y, Yin L, Lu PH, et al. Differential gene expression in neural stem cells and oligodendrocyte precursor cells: a cDNA microarray analysis. J Neurosci Res 2004 78 : 637 46.
29. Fu SL, Hu JG, Li Y, Yin L, Jin JQ, Xu XM, et al. Induction of rat neural stem cells into oligodendrocyte precursor cells. Acta Physiol Sin 2005 57 : 132 8.
30. Zhang SC, Lundberg C, Lipsitz D, O'Connor LT, Duncan ID. Generation of ligodendroglial progenitors from neural stem cells. J Neurocytol 1998 27 : 475 89.
31. Ben-Hur T, Ben-Menachem O, Furer V, Einstein O, Mizrachi-Kol R, Grigoriadis N. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 2003 24 : 623 31.
32. Aspberg A, Miura R, Bourdoulous S, Shimonaka M, Heinegard D, Schachner M, et al. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci USA 1997 94 : 10 116 21.
33. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 2000 57 : 276 89.
34. Dutt S, Kleber M, Matasci M, Sommer L, Zimmermann DR. Versican V0 and V1 guide migratory neural crest cells. J Biol Chem 2006 281 : 12 : 123 31.
35. Celio MR, Spreafico R, De BS, Vitellaro-Zuccarello L. Perineu-ronal nets: past and present. Trends Neurosci 1998 21 : 510 5.
36. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002 298 : 1248 51.
37. Milev P, Maurel P, Chiba A, Mevissen M, Popp S, Yamaguchi Y, et al. Differential regulation of expression of hyaluronan-bind-ing proteoglycans in developing brain: aggrecan, versican, neurocan, and brevican. Biochem Biophys Res Commun 1998 247 : 207 12.
38. Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, et al. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-in-hibitory proteoglycan is NG2. J Neurosci 1999 19 : 8778 88.
39. Levine JM, Stincone F, Lee YS. Development and differentiation of glial precursor cells in the rat cerebellum. Glia 1993 7 : 307 21.
40. Giulian D, Chen J, Ingeman JE, George JK, Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989 9 : 4416 29.
41. Smith GM, Strunz C. Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 2005 52 : 209 18.
42. Boockvar JA, Schouten J, Royo N, Millard M, Spangler Z, Castelbuono D, et al. Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells. Neurosurgery 2005 56 : 163 71.
43. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004 101 : 18 117 22.
44. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIn-tosh TK. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res 1996 36 : 287 91.
45. Hayashi M, Ueyama T, Nemoto K, Tamaki T, Senba E. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 2000 17 : 203 18.
46. Nakamura M, Houghtling RA, MacArthur L, Bayer BM, Bregman BS. Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 2003 184 : 313 25.
47. Yan P, Li Q, Kim GM, Xu J, Hsu CY, Xu XM. Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J Neurotrauma 2001 18 : 563 8.
48. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 2002 22 : 2792 803.
49. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002 416 : 636 40.
50. Chau CH, Shum DK, Li H, Pei J, Lui YY, Wirthlin L, et al. Chondroitinase ABC enhances axonal regrowth through Schwann cell-seeded guidance channels after spinal cord injury. FASEB J 2004 18 : 194 6.